Literature DB >> 26088735

Re: Long-Term Outcomes in Patients with Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233.

Ofer N Gofrit1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26088735     DOI： 10.1016/j.eururo.2015.03.057

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

1.  Antibiotic heliomycin and its water-soluble 4-aminomethylated derivative provoke cell death in T24 bladder cancer cells by targeting sirtuin 1 (SIRT1).

Authors:  Ming Hung Lin; Atikul Islam; Yen-Hui Liu; Chia-Wei Weng; Jun-Han Zhan; Ru-Hao Liang; Alexander S Tikhomirov; Andrey E Shchekotikhin; Pin Ju Chueh
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

2.  Integrated proteomic and phosphoproteomic analyses of cisplatin-sensitive and resistant bladder cancer cells reveal CDK2 network as a key therapeutic target.

Authors:  Jae Hun Jung; Sungyong You; Jae Won Oh; Junhee Yoon; Austin Yeon; Muhammad Shahid; Eunho Cho; Vikram Sairam; Taeeun D Park; Kwang Pyo Kim; Jayoung Kim
Journal:  Cancer Lett       Date:  2018-08-24       Impact factor: 9.756
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.